China Animal Husbandry Industry's subsidiary obtains new veterinary drug registration certificate for pentobarbital sodium

Regulation
โดย Jiemian·CN·Read original
Summary · why it matters

China Animal Husbandry Industry announced that pentobarbital sodium, jointly applied for by its controlling subsidiary Hubei Zhongmu Anda Pharmaceutical, China Animal Husbandry Group, and Chengdu Animel Biotechnology, has been approved by the Ministry of Agriculture and Rural Affairs as a new veterinary drug in Category III, with a new veterinary drug registration certificate issued and a three-year monitoring period. The product is used for euthanasia of laboratory animals and is an intermediate-acting barbiturate central sedative. The announcement shows that Hubei Zhongmu Anda Pharmaceutical spent 225,800 yuan on research and development for this project.

Impact on stocks 1

Others▲ · 1 stocks

Off-coverage companies 3

湖北中牧安达药业Private▲ Positive
Technologyrelevance

Controlling subsidiary Hubei Zhongmu Anda Pharmaceutical jointly applied and obtained the new veterinary drug registration certificate.

中国牧工商集团有限公司Private▲ Positive
Technologyrelevance

China Animal Husbandry Group jointly applied for the new veterinary drug registration certificate.

成都艾尼迈尔生物科技Private▲ Positive
Technologyrelevance

Chengdu Animel Biotechnology jointly applied for the new veterinary drug registration certificate.

© 2026 MarketDXNews